WYZGA MICHAEL S has filed 13 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 66000 shares of Mereo BioPharma Group plc ($MREO) on February 26, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Mereo BioPharma Group plc | $MREO | WYZGA MICHAEL S | Not found | A | Share Options (Right to buy) | 66000 | $0.00 | 66,000.0000 | 799,947,013 | 9999.99% | 0.01% |
| Jan. 1, 2026 | X4 Pharmaceuticals, Inc | $XFOR | WYZGA MICHAEL S | Director | A | Stock Option (right to buy) | 110000 | $0.00 | 0.0000 | 43,272,773 | 0.00% | 0.25% |
| June 9, 2025 | X4 Pharmaceuticals, Inc | $XFOR | WYZGA MICHAEL S | Director | A | Common Stock | 1500 | $0.00 | 5,555.0000 | 201,062,211 | 36.99% | 0.00% |
| April 17, 2025 | Tvardi Therapeutics, Inc. | $TVRD | WYZGA MICHAEL S | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| April 15, 2025 | Tvardi Therapeutics, Inc. | $TVRD | WYZGA MICHAEL S | Not found | A | Stock Option (right to buy) | 18441 | $0.00 | 18,441.0000 | 1,524,116 | 9999.99% | 1.21% |
| Feb. 5, 2025 | Mereo BioPharma Group plc | $MREO | WYZGA MICHAEL S | Not found | A | Deferred Restricted Stock Units | 30487 | $0.00 | 30,487.0000 | 739,624,264 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Mereo BioPharma Group plc | $MREO | WYZGA MICHAEL S | Not found | A | Share Options (Right to buy) | 55000 | $0.00 | 55,000.0000 | 739,624,264 | 9999.99% | 0.01% |
| June 17, 2024 | Mereo BioPharma Group plc | $MREO | WYZGA MICHAEL S | Not found | A | American Depositary Shares representing Ordinary Shares | 25050 | $3.99 | 25,050.0000 | 659,453,921 | 9999.99% | 0.00% |
| June 10, 2024 | X4 Pharmaceuticals, Inc | $XFOR | WYZGA MICHAEL S | Director | A | Common Stock | 45000 | $0.00 | 121,667.0000 | 177,812,480 | 58.70% | 0.03% |
| Feb. 8, 2024 | Mereo BioPharma Group plc | $MREO | WYZGA MICHAEL S | Not found | A | Share Options (Right to buy) | 45000 | $0.00 | 45,000.0000 | 659,453,921 | 9999.99% | 0.01% |
| Feb. 8, 2024 | Mereo BioPharma Group plc | $MREO | WYZGA MICHAEL S | Not found | A | Deferred Restricted Stock Units | 30783 | $0.00 | 30,783.0000 | 659,453,921 | 9999.99% | 0.00% |
| Aug. 18, 2023 | X4 Pharmaceuticals, Inc | $XFOR | WYZGA MICHAEL S | Director | P | Common Stock | 25000 | $1.20 | 76,667.0000 | 63,525,845 | 48.39% | 0.04% |
| June 13, 2023 | X4 Pharmaceuticals, Inc | $XFOR | WYZGA MICHAEL S | Director | A | Common Stock | 45000 | $0.00 | 51,667.0000 | 63,525,845 | 674.97% | 0.07% |